Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927989 · ClinicalTrials.gov registry record · NA
Tobacco Treatment in the Context of Lung Cancer Screening
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03927989 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 48 participants.
The verdict
NCT03927989, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The proposed study will test a medication plus text messaging intervention specifically designed for lung cancer screening patients. Half of the patients will receive standard of care, and half will receive the treatment intervention.
Interventions
- BEHAVIORAL Text messaging plus nicotine replacement therapy
- OTHER Standard Care at Lung Cancer Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03927989
The ClinicalTrials.gov registry entry for NCT03927989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Text messaging plus nicotine replacement therapy is the first listed.
NCT03927989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03927989 about?
NCT03927989 is a clinical study titled "Tobacco Treatment in the Context of Lung Cancer Screening". The proposed study will test a medication plus text messaging intervention specifically designed for lung cancer screening patients. Half of the patients will receive standard of care, and half will receive the treatment intervention.
What is the current status of trial NCT03927989?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2019-04-15. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT03927989?
The interventions under investigation include: Text messaging plus nicotine replacement therapy (BEHAVIORAL), Standard Care at Lung Cancer Screening (OTHER).
Who is sponsoring clinical trial NCT03927989?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.